Daniel Passeri | executive |
Matteo Levisetti | executive |
Anish Suri | executive |
Kerri-Ann Millar | executive |
Reni Benjamin | analyst |
Edward Tenthoff | analyst |
Good afternoon, ladies and gentlemen, and welcome to the Cue Biopharma Third Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this call is being recorded today, Thursday, November 9, 2023.I would now like to turn over the conference to Dan Passeri, Chief Executive Officer. Please go ahead.
Yes, and good afternoon, everyone.
As a reminder, this presentation and discussion is being recorded and will be available on our website for the next 30 days.